Clinical Trial Update: The First-in-human Study of SRN-001 in Healthy Participants [Phase 1]

View source ↗

Summary

This report communicates completion of a first-in-human Phase 1 study of SRN-001 in healthy participants to evaluate safety and tolerability for potential use i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Drugs mentioned

• SRN-001

Snippet

Sponsor: siRNAgen Therapeutics Inc. | Conditions: Idiopathic Pulmonary Fibrosis | Phase 1 | Status: COMPLETED